InsiderDB

Lobbying disclosures · Lobbying report

ABBV: third_quarter 2026 lobbying report

federal budget issues drug pricing in federal programs, transparency, prescription drug pricing and access, beneficiary access, IRA Part B, Part D, drug pricing and access, negotiation,

Follow ABBV
Became public
Oct 20, 2026, 12:04 PM EDT
Event / period date
Not stated
Collected
Nov 9, 2026, 9:38 AM EST

Why this is connected

Exact legal-name match: AbbVie Inc. (https://www.sec.gov/Archives/edgar/data/1551152/).

Reported lobbying amounts

Income: $60,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/91bed0ca-56e0-4700-9bc5-c9e049c828f0/","filing_uuid":"91bed0ca-56e0-4700-9bc5-c9e049c828f0","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/91bed0ca-56e0-4700-9bc5-c9e049c828f0/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Jennifer B. Young","dt_posted":"2026-10-20T12:04:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1299 Pennsylvania Ave NW","registrant_address_2":"FL 12","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":304736,"url":"https://lda.gov/api/v1/registrants/304736/","house_registrant_id":38067,"name":"TARPLIN, DOWNS & YOUNG, LLC","description":"Health care policy and regulatory and legislative consulting","address_1":"1299 Pennsylvania Ave NW","address_2":"FL 12","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIFER B. YOUNG","contact_telephone":"","dt_updated":"2026-07-28T09:23:12.888741-04:00"},"client":{"id":181309,"url":"https://lda.gov/api/v1/clients/181309/","client_id":1005142,"name":"ABBVIE INC.","general_description":"Abbvie is a global biopharmaceutical company focused on developing leading-edge therapies.","client_government_entity":false,"client_self_select":false,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-07-15"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"federal budget issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141160,"prefix":null,"prefix_display":null,"first_name":"MARGARET","nickname":"MEG","middle_name":null,"last_name":"JOSEPH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141752,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"FISE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147125,"prefix":"mr","prefix_display":"MR.","first_name":"PARICK","nickname":null,"middle_name":"BRAERTON","last_name":"CARROLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26124,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":"B","last_name":"YOUNG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7749,"prefix":null,"prefix_display":null,"first_name":"RAISSA","nickname":null,"middle_name":"H","last_name":"DOWNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61537,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":"T","last_name":"MURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64513,"prefix":null,"prefix_display":null,"first_name":"CHARLOTTE","nickname":null,"middle_name":"SPEARS","last_name":"IVANCIC","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65078,"prefix":null,"prefix_display":null,"first_name":"PAMELA","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71297,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":"H","last_name":"MURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"drug pricing in federal programs, transparency, prescription drug pricing and access, beneficiary access, IRA","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":7749,"prefix":null,"prefix_display":null,"first_name":"RAISSA","nickname":null,"middle_name":"H","last_name":"DOWNS","suffix":null,"suffix_display":null},"covered_position":"Prin. Dep. Asst. Sec for Leg.-HHS; Dep. Asst. Sec. for Leg.-HSS; Staff Dir., Sub Cmte. on Employment, Sen. HELP Cmte.","new":false},{"lobbyist":{"id":26124,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":"B","last_name":"YOUNG","suffix":null,"suffix_display":null},"covered_position":"Asst. Sec. for Leg.- HHS; Dep. Asst. Sec for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff. Sen. Cmte. on Finance","new":false},{"lobbyist":{"id":61537,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":"T","last_name":"MURRAY","suffix":null,"suffix_display":null},"covered_position":"Senior Policy Advisor, Democratic Whip Steny Hoyer; Leg. Asst., Rep. Mike Thompson, Rep. Bob Matsui, and Sen. Bob Graham","new":false},{"lobbyist":{"id":64513,"prefix":null,"prefix_display":null,"first_name":"CHARLOTTE","nickname":null,"middle_name":"SPEARS","last_name":"IVANCIC","suffix":null,"suffix_display":null},"covered_position":"Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner","new":false},{"lobbyist":{"id":65078,"prefix":null,"prefix_display":null,"first_name":"PAMELA","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Sen. HELP Cmte.; Staff Dir., Sen. HELP Cmte.; Counsel to Asst. AG, Civil Div., Dept. of Justice; Spec. Counsel, Ofc of Leg. Affairs, Dept. of Justice; Counsel and LA, Sen. Carol Moseley-Braun","new":false},{"lobbyist":{"id":71297,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":"H","last_name":"MURRY","suffix":null,"suffix_display":null},"covered_position":"Staff Dir., Sub. Cmte. on Helath, Ways and Means Cmte; Sr. Policy Adivsor, Maj. Leader McCarthy; Policy Advisor, Maj. Whip McCarthy; Prof. Staff, Republicans Study Cmte.; Leg. Aide, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price","new":false},{"lobbyist":{"id":141160,"prefix":null,"prefix_display":null,"first_name":"MARGARET","nickname":"MEG","middle_name":null,"last_name":"JOSEPH","suffix":null,"suffix_display":null},"covered_position":"CoS for Sen. Kyrsten Sinema, CoS for Rep. Kyrsten Sinema, CoS for Rep. Bobby Bright, CoS for Rep. Jim Matheson, Clerk for House Rules Cmte.","new":false},{"lobbyist":{"id":141752,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"FISE","suffix":null,"suffix_display":null},"covered_position":"Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform","new":false},{"lobbyist":{"id":147125,"prefix":"mr","prefix_display":"MR.","first_name":"PARICK","nickname":null,"middle_name":"BRAERTON","last_name":"CARROLL","suffix":null,"suffix_display":null},"covered_position":"Leg Asst. Rep. Ray LaHood, Leg Dir. Rep. Kevin Yoder, PSM Senate Appropriations Cmte.","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Part B, Part D, drug pricing and access, negotiation,","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":7749,"prefix":null,"prefix_display":null,"first_name":"RAISSA","nickname":null,"middle_name":"H","last_name":"DOWNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26124,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":"B","last_name":"YOUNG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61537,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":"T","last_name":"MURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64513,"prefix":null,"prefix_display":null,"first_name":"CHARLOTTE","nickname":null,"middle_name":"SPEARS","last_name":"IVANCIC","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65078,"prefix":null,"prefix_display":null,"first_name":"PAMELA","nickname":null,"middle_name":null,"last_name":"SMITH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71297,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":"H","last_name":"MURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141160,"prefix":null,"prefix_display":null,"first_name":"MARGARET","nickname":"MEG","middle_name":null,"last_name":"JOSEPH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141752,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"FISE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147125,"prefix":"mr","prefix_display":"MR.","first_name":"PARICK","nickname":null,"middle_name":"BRAERTON","last_name":"CARROLL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Price change after we could observe it

+0.37% ABBV

Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.

Congressional trading in ABBV

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.